BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3064801)

  • 1. The specificity of nephritogenic antibodies. V. Glomerular localization of anti-GP 330 and anti-GP 90 antibodies present in passive Heymann serum.
    Bagchus WM; Hoedemaeker PJ; Slegers JF; Bakker WW
    Br J Exp Pathol; 1988 Dec; 69(6):855-64. PubMed ID: 3064801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe glomerular epithelial cell damage does not prevent passive Heyman nephritis in rats.
    Bertani T; Remuzzi G; Poggi A; Delaini F; Sacchi G; Morassi L; Verroust P; Mecca G; Donati MB
    Clin Exp Immunol; 1983 Jan; 51(1):38-44. PubMed ID: 6339125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of an antigen distinct from the Heymann antigen in membranous glomerulonephritis in the mouse.
    Assmann KJ; Ronco P; Tangelder MM; Lange WP; Verroust P; Koene RA
    Lab Invest; 1989 Jan; 60(1):138-46. PubMed ID: 2642986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymocytes reacting with heterologous antibodies against GP 330 in autologous immune complex glomerulopathy (AICG) in the rat. The relation between susceptibility for AICG and anti-GP 330-binding thymocytes.
    Bagchus WM; Hoedemaeker PJ; Vos JT; Bakker WW
    Immunobiology; 1989 Oct; 179(4-5):432-44. PubMed ID: 2693345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephritogenic and non-nephritogenic epithelial antigens in autoimmune and passive Heymann nephritis.
    Miettinen A; Törnroth T; Ekblom P; Virtanen I; Linder E
    Lab Invest; 1984 Apr; 50(4):435-46. PubMed ID: 6708453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The specificity of nephritogenic antibodies. II. Immune complex glomerulopathy in rats induced by heterologous antithymocyte serum.
    Bagchus WM; Donga J; Hoedemaeker PJ; Bakker WW
    Transplantation; 1984 Aug; 38(2):165-9. PubMed ID: 6235648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulatory antigen of Heymann nephritis. II. Isolation of a 70,000 MW antigen from normal rat serum which cross-reacts with Heymann nephritis antigen.
    Singh AK; Schwartz MM
    Immunology; 1986 Nov; 59(3):451-8. PubMed ID: 3539772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive Heymann nephritis in pre- and post-natal rats.
    Challice J; Barabas AZ; Cornish J; Bruce JW; Lannigan R
    Br J Exp Pathol; 1986 Dec; 67(6):915-24. PubMed ID: 3542009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of antigens and antibody specificities involved in Heymann nephritis.
    Kamata K; Baird LG; Erikson ME; Collins AB; McCluskey RT
    J Immunol; 1985 Oct; 135(4):2400-8. PubMed ID: 2411795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
    Kerjaschki D; Farquhar MG
    J Exp Med; 1983 Feb; 157(2):667-86. PubMed ID: 6337231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential localization of antibody to multiple regions of the glomerular capillary wall in passive Heymann nephritis.
    Rydel JJ; Schwartz MM; Singh AK
    Lab Invest; 1989 Apr; 60(4):492-8. PubMed ID: 2651800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new glomerular antigen in passive Heymann's nephritis.
    Jeraj K; Vernier RL; Sisson SP; Michael AF
    Br J Exp Pathol; 1984 Aug; 65(4):485-98. PubMed ID: 6380558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of immunoglobulin M antibodies around the glomerular capillaries and in the mesangium of normal and passive Heymann nephritis rats.
    Barabas AZ; Cole CD; Barabas AD; Cowan JM; Yoon CS; Waisman DM; Lafreniere R
    Int J Exp Pathol; 2004 Oct; 85(4):201-12. PubMed ID: 15312125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of anti-gp330 and anti-dipeptidyl peptidase type IV antibodies in the induction of glomerular damage.
    van Leer EH; de Roo GM; Bruijn JA; Hoedemaeker PJ; de Heer E
    Exp Nephrol; 1993; 1(5):292-300. PubMed ID: 7915960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specificity of nephritogenic antibodies. III. Binding of anti-Fx1A antibodies in glomeruli is dependent on dual specificity.
    Bagchus WM; Vos JT; Hoedemaeker PJ; Bakker WW
    Clin Exp Immunol; 1986 Mar; 63(3):639-47. PubMed ID: 3519014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein.
    Kerjaschki D; Ullrich R; Exner M; Orlando RA; Farquhar MG
    J Exp Med; 1996 May; 183(5):2007-15. PubMed ID: 8642311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
    Kerjaschki D
    Verh Dtsch Ges Pathol; 1989; 73():24-35. PubMed ID: 2482609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.